minimal gastrointestinal , bone marrow , and renal toxicities during therapy suggest that sustained free platinum concentrations in ascites may be obtained without significant toxicity and support the intraperitoneal route of administration as an effective strategy for cisplatin therapy of intra-abdominal malignancies .
C0003962
ascites
C0230168
intra-abdominal